NASDAQ: LYRALyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?
Insider buying vs selling
Have Lyra Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LYRA insiders and whales buy or sell their stock.
LYRA Shareholders
What type of owners hold Lyra Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 962.58% | 12,757,562 | $110.29M | Institution |
| Blackrock Inc | 227.79% | 3,018,986 | $26.10M | Institution |
| Edward T. Anderson | 199.21% | 2,640,228 | $22.82M | Insider |
| Perceptive Advisors LLC | 194.43% | 2,576,892 | $22.28M | Insider |
| Nbvm GP LLC | 190.27% | 2,521,745 | $21.80M | Insider |
| Vanguard Group Inc | 133.22% | 1,765,585 | $15.26M | Institution |
| Samsara Biocapital LLC | 104.89% | 1,390,130 | $12.02M | Institution |
| Maria Palasis | 83.00% | 1,100,000 | $9.51M | Insider |
| Ikarian Capital LLC | 79.84% | 1,058,148 | $9.15M | Institution |
| Geode Capital Management LLC | 76.66% | 1,016,004 | $8.78M | Institution |
LYRA vs Biotech Stocks
Lyra Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.